News & Events

Press Releases

June 13, 2023

HepQuant Announces Additions to the Executive Leadership Team to Drive Commercialization

Kelly R. Pitts, PhD, Chief Operating Officer; Carrie Mulherin, MBA, Chief Commercial Officer; Shailesh Chavan, MD, Chief Medical Officer; Paige Nardi, MBA VP Market Access Denver, CO – June 13, 2023 – HepQuant, LLC, a leader transforming the management of liver diseases, announces key additions to its executive leadership team….

April 14, 2023

Kelly R. Pitts, Ph.D., Appointed Chief Operating Officer

Medical Diagnostics Industry Veteran with Biotech and Biopharma Experience Will Guide Operations DENVER (Apr. 14, 2023) — HepQuant, LLC, a Denver, Colorado-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, today announced its has chosen Kelly R. Pitts, Ph.D., as its new Chief…


November 10, 2023 - November 14, 2023Boston, MA

AASLD, The Liver Meeting